top of page
Tirzepatide 10 mg
Unit Size10 mg/vial
Unit Quantity1 Amber Vial
Molecular FormulaC225H348N48O68
Molecular Weight4813.64
SequenceIUPAC Name
AppearanceWhite Powder
Peptide Purity>98.1%
SolubilitySoluble in water or 1% acetic acid
 
Tirzepatide, known as LY3298176, represents a groundbreaking development in the treatment of type 2 diabetes (T2D), introducing a unique dual agonist approach that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual-action mechanism effectively mimics the natural effects of GIP while enhancing cAMP synthesis at GLP-1 receptors, significantly boosting insulin secretion and reducing glucagon levels, outperforming the effects of treatments that target either receptor alone.
 
With a structure of 39 amino acids and a C20 fatty di-acid moiety, Tirzepatide offers an extended half-life, allowing for a convenient once-weekly dosing regimen that promotes better adherence. Its approval by the FDA in May 2022 for T2D management marks it as the first dual GLP-1 and GIP receptor agonist, highlighting its innovative therapeutic approach.
 
Tirzepatide's efficacy extends beyond glycemic control to include notable benefits in weight management, distinguishing it in clinical trials as superior to existing T2D treatments. Its mechanism involves biased agonism at the GLP-1 receptor, favoring cAMP production, which is believed to enhance its therapeutic effects. Additionally, Tirzepatide's influence on adiponectin levels points to potential cardioprotective properties by modulating lipid and glucose metabolism, adipose tissue inflammation, and differentiation.
 
The ongoing exploration of Tirzepatide in scientific research, driven by its comprehensive benefits in T2D treatment and possible cardiovascular advantages, places it at the forefront of diabetes care. The anticipation for future studies to uncover its long-term impacts and cardiovascular outcomes signifies the medical community's enthusiasm for fully understanding and utilizing Tirzepatide's extensive therapeutic potential.
 
Please be aware that the information provided is based on scientific research and is for educational and informational purposes only. It is the subject of ongoing studies to further understand its potential and applications. Individuals should consult healthcare professionals before considering any peptide for therapeutic use.

Tirzepatide 10 mg

$190.00Price

    Product Use: This PRODUCT IS INTENDED SOLELY FOR RESEARCH PURPOSES. It is designated for in vitro testing and laboratory experiments only. All information provided on this website is for educational use. The introduction of this substance into humans or animals is illegal. Only licensed and qualified professionals should handle this product. It is not a drug, food, or cosmetic, and must not be misrepresented or misused as one.

    © 2024  All Rights Reserved

    MolecularEdge

    ​

    All products on this website are intended for research and development purposes only and are not for human consumption in any form. The claims made on this site have not been reviewed by the U.S. Food and Drug Administration. The products and statements provided by this company are not intended to diagnose, treat, cure, or prevent any disease.

    ​

    Molecular Edge is a supplier of chemicals, not a compounding pharmacy or a chemical compounding facility as outlined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Additionally, Molecular Edge is not an outsourcing facility as defined under Section 503B of the same act.

    bottom of page